ID
41475
Descripción
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 - See https://clinicaltrials.gov/ct2/show/NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. The Adverse Events Form has to be filled in each time such Event occurs during the Study. Please use one Instance of this Form for every 12 Records.
Link
https://clinicaltrials.gov/ct2/show/NCT00039858
Palabras clave
Versiones (1)
- 21/10/20 21/10/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
21 de octubre de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Adverse Events
- StudyEvent: ODM
Descripción
Did the patient experience any AEs?
Alias
- UMLS CUI-1
- C0877248
Descripción
Adverse Events
Alias
- UMLS CUI-1
- C0877248
Descripción
Use a new instance if more than 12 lines are required.
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C2348184
Descripción
(List all events during the study - including 30-day follow-up period)
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0877248
Descripción
(dd-mmm-yyyy)
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0808070
Descripción
(0000-2359)
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1301880
Descripción
(dd-mmm-yyyy)
Tipo de datos
date
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0806020
Descripción
(0000-2359)
Tipo de datos
time
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1522314
Descripción
(List all Applicable)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1704758
- UMLS CUI [1,3]
- C0549184
Descripción
(List all Applicable)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1704758
- UMLS CUI [2]
- C0558681
Descripción
(List all Applicable)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1704758
- UMLS CUI [2]
- C2826232
Descripción
(List all Applicable)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1704758
- UMLS CUI [2,1]
- C0304229
- UMLS CUI [2,2]
- C1512900
Descripción
(List all Applicable) (record on Concomitant Medications form)
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1704758
- UMLS CUI [2,1]
- C0686904
- UMLS CUI [2,2]
- C0087111
Descripción
Adverse event outcome
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1705586
Descripción
Adverse event relationship to study drug
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0439849
- UMLS CUI [1,3]
- C0304229
Descripción
Adverse event severity
Tipo de datos
integer
Alias
- UMLS CUI [1]
- C1710066
Descripción
*Serious event requires SAE page, AND must be reported via fax to GSK within 24 hours at
Tipo de datos
text
Alias
- UMLS CUI [1]
- C1710056
Similar models
Adverse Events
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C2348184 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])
C1704758 (UMLS CUI [1,2])
C0549184 (UMLS CUI [1,3])
C1704758 (UMLS CUI [1,2])
C0558681 (UMLS CUI [2])
C1704758 (UMLS CUI [1,2])
C2826232 (UMLS CUI [2])
C1704758 (UMLS CUI [1,2])
C0304229 (UMLS CUI [2,1])
C1512900 (UMLS CUI [2,2])
C1704758 (UMLS CUI [1,2])
C0686904 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C0439849 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])